<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Supernus Pharmaceuticals, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Supernus Pharmaceuticals, Inc.

    Supernus Pharmaceuticals, Inc. is a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases. The Company currently markets Trokendi XRÂŽ (extended-release topiramate) for the prophylaxis of migraine and the treatment of epilepsy, and Oxtellar XRÂŽ (extended-release oxcarbazepine) for the treatment of epilepsy. The Company is also developing several product candidates to address large market opportunities in the CNS market, including SPN-810 for the treatment of Impulsive Aggression in ADHD patients, SPN-812 for the treatment of ADHD and SPN-604 for the treatment of bipolar disorder. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Jack A. Khattar
    • FOUNDED
      2005
    • EMPLOYEES
      251-500
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Syndax Pharmaceuticals, Inc.

    Syndax Pharmaceuticals, Inc.

    Syndax Pharmaceuticals, Inc. is a late-stage biopharmaceutical company focused on ...

    Syndax Pharmaceuticals, Inc. is a late-stage bi...

    Filing Type:    PU
    SelenBio, Inc.

    SelenBio, Inc.

    SelenBio, Inc is a biotechnology company specializing in the prevention of bacteri...

    SelenBio, Inc is a biotechnology company specia...

    Amount Raised:    $94,956.00
    Fundraising Status:    EC
    Filing Type:    CF
    Cesca Therapeutics Inc.

    Cesca Therapeutics Inc.

    Cesca is a leading regenerative medicine company that develops, commercializes and...

    Cesca is a leading regenerative medicine compan...

    Filing Type:    PU
    Rocket Pharmaceuticals, Inc.

    Rocket Pharmaceuticals, Inc.

    Rocket Pharmaceuticals, Inc. is an emerging, clinical-stage biotechnology company ...

    Rocket Pharmaceuticals, Inc. is an emerging, cl...

    Filing Type:    PU
    Altimmune, Inc.

    Altimmune, Inc.

    Altimmune is a clinical-stage immunotherapeutics company focused on the developmen...

    Altimmune is a clinical-stage immunotherapeutic...

    Filing Type:    PU
    Merrimack Pharmaceuticals, Inc.

    Merrimack Pharmaceuticals, Inc.

    Merrimack is a biopharmaceutical company based in Cambridge, Massachusetts that is...

    Merrimack is a biopharmaceutical company based ...

    Filing Type:    PU
    Therapix Biosciences Ltd.

    Therapix Biosciences Ltd.

    Therapix Biosciences Ltd. (NASDAQ: TRPX) is a specialty clinical-stage pharmaceuti...

    Therapix Biosciences Ltd. (NASDAQ: TRPX) is a s...

    Filing Type:    PU
    Aquestive Therapeutics, Inc.

    Aquestive Therapeutics, Inc.

    Aquestive Therapeutics is a specialty pharmaceutical company that advances and com...

    Aquestive Therapeutics is a specialty pharmaceu...

    Filing Type:    PU
    Axsome Therapeutics, Inc.

    Axsome Therapeutics, Inc.

    Axsome Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing...

    Axsome Therapeutics, Inc. is a clinical-stage b...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.